Personal and Psychosocial Predictors of Doping Use in Physical Activity Settings: A Meta-Analysis

Sports Medicine

Volumn 44, Issue 11, 2014, Pages 1603-1624

  Ntoumanis, Nikos ^a   Ng, Johan Y Y ^b   Barkoukis, Vassilis ^c   Backhouse, Susan ^d  

^a CURTIN UNIVERSITY   (Australia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORMANCE ENHANCING SUBSTANCE;

AGE; ATHLETE; ATTITUDE TO HEALTH; BEHAVIOR; DIET SUPPLEMENTATION; DOPING; FRIEND; HUMAN; META ANALYSIS; MORALITY; PSYCHOLOGICAL THEORY; PSYCHOLOGY; SELF CONCEPT; SEX DIFFERENCE; SOCIAL NORM; THEORETICAL MODEL;

AGE FACTORS; ATHLETES; DIETARY SUPPLEMENTS; DOPING IN SPORTS; FRIENDS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MODELS, THEORETICAL; MORALS; PERFORMANCE-ENHANCING SUBSTANCES; PSYCHOLOGICAL THEORY; SELF EFFICACY; SEX FACTORS; SOCIAL NORMS;

EID: 84930616997     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0240-4     Document Type: Review

References (118)

1. WADA. World anti-doping code. Montreal: World Anti-Doping Agency; 2009.
2. Baron DA, Martin DM, Magd SA. Doping in sports and its spread to at-risk populations: an international review. World Psychiatry. 2007;6(2):118–23.
3. Pitsch W, Emrich E. The frequency of doping in elite sport: results of a replication study. Int Rev Sociol Sport. 2011;47(5):559–80.
4. Dunn M, Mazanov J, Sitharthan G. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey. Clin J Sport Med. 2009;19(3):222–7.
5. Blouin AG, Goldfield GS. Body image and steroid use in male bodybuilders. Int J Eat Disord. 1995;18(2):159–65.
6. Laure P. Epidemiologic approach of doping in sport: a review. J Sports Med Phys Fit. 1997;37(3):218–24.
7. Lentillon-Kaestner V, Ohl F. Can we measure accurately the prevalence of doping? Scand J Med Sci Sports. 2011;21(6):e132–42.
8. Uvacsek M, Nepusz T, Naughton DP, et al. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes. Scand J Med Sci Sports. 2011;21(2):224–34.
9. Petróczi A, Aidman EV, Nepusz T. Capturing doping attitudes by self-report declarations and implicit assessment: a methodology study. Subst Abuse Treat Prev Policy. 2008;3:9.
10. Sottas P-E, Robinson N, Fischetto G, et al. Prevalence of blood doping in samples collected from elite track and field athletes. Clin Chem. 2011;57(5):762–9.
11. Fahey J. WADA in 2013. WADA Media Symposium. London; 12 Feb 2013. http://www.wada-ama.org/Documents/News_Center/Speeches_Presentations/WADA-2013-Media-Symposium-President-Speech.pdf. Accessed 4 Jun 2014.
12. Working Group on the (in) effectiveness of testing. Report to WADA Executive Committee on lack of effectiveness of testing programs. 2013.
13. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.
14. Fishbein M, Cappella JN. The role of theory in developing effective health communications. J Commun. 2006;56(s1):S1–17.
15. Goulet C, Valois P, Buist A, et al. Predictors of the use of performance-enhancing substances by young athletes. Clin J Sport Med. 2010;20(4):243–8.
16. Lazuras L, Barkoukis V, Rodafinos A, et al. Predictors of doping intentions in elite-level athletes: a social cognition approach. J Sport Exerc Psychol. 2010;32(5):694–710.
17. Lucidi F, Zelli A, Mallia L, et al. The social-cognitive mechanisms regulating adolescents’ use of doping substances. J Sports Sci. 2008;26(5):447–56.
18. Wiefferink CH, Detmar SB, Coumans B, et al. Social psychological determinants of the use of performance-enhancing drugs by gym users. Health Educ Res. 2008;23(1):70–80.
19. Zelli A, Mallia L, Lucidi F. The contribution of interpersonal appraisals to a social-cognitive analysis of adolescents’ doping use. Psychol Sport Exerc. 2010;11(4):304–11.
20. Fishbein M. An integrative model for behavioral prediction and its application to health promotion. In: DiClemente RJ, Crosby RA, Kegler MC, editors. Emerging theories in health promotion practice and research. 2nd ed. New York: Wiley; 2009. p. 215–34.
21. Barkoukis V, Lazuras L, Tsorbatzoudis H, et al. Motivational and sportspersonship profiles of elite athletes in relation to doping behavior. Psychol Sport Exerc. 2011;12(3):205–12.
22. Dodge TL, Jaccard JJ. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health. 2006;39(3):367–73.
23. Backhouse SH, Whitaker L, Petróczi A. Gateway to doping? Supplement use in the context of preferred competitive situations, doping attitude, beliefs, and norms. Scand J Med Sci Sports. 2013;23(2):244–52.
24. Whitaker L, Long J, Petróczi A, et al. Using the prototype willingness model to predict doping in sport. Scand J Med Sci Sports. in press.
25. Backhouse S, McKenna J, Robinson S, et al. International literature review: Attitudes, behaviors, knowledge and education–drugs in sport: past, present and future. Report to the World Anti-Doping Agency (WADA). 2007.
26. Elliot DL, Goldberg L, Moe EL, et al. Long-term outcomes of the ATHENA (athletes targeting healthy exercise & nutrition alternatives) program for female high school athletes. J Alcohol Drug Educ. 2008;52(2):73–92.
27. Chng CL, Moore A. A study of steroid use among athletes: knowledge, attitude and use. Health Educ. 1990;21(6):12–7.
28. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 1991.
29. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School);1993.
30. Brower KJ, Blow FC, Hill EM. Risk factors for anabolic-androgenic steroid use in men. J Psychiatr Res. 1994;28(4):369–80.
31. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 1995.
32. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National College); 1995.
33. Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol. 1995;48(1):9–11.
34. Allemeier MF. CIAU athletes’ use and intentions to use performance enhancing drugs: a study utilizing the theory of planned behaviour [Master’s thesis]. The University of British Columbia; 1996.
35. Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: the adolescents training and learning to avoid steroids (ATLAS) program. J Am Med Assoc. 1996;276(19):1555–62.
36. Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med. 1996;6(1):9–14.
37. Vogels T, Brugman E, Coumans B, et al. Correlates of the use of performance-enhancing drugs among young patrons of gymnasiums in the Netherlands. Drugs (Abingdon Engl). 1996;3(1):39–48.
38. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National Alternative High School); 1998.
39. Faigenbaum AD, Zaichkowsky LD, Gardner DE, et al. Anabolic steroid use by male and female middle school students. Pediatrics. 1998;101:e6.
40. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 1999.
41. Kindlundh AMS, Isacson DGL, Berglund L, et al. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction. 1999;94(4):543–53.
42. Goldberg L, Mackinnon DP, Elliot DL, et al. The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors. Arch Pediatr Adolesc Med. 2000;154:332–8.
43. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 2001.
44. Pedersen W, Wichstrøm L. Adolescents, doping agents, and drug use: a community study. J Drug Issues. 2001;31(2):517–42.
45. Miller KE, Barnes GM, Sabo D, et al. A comparison of health risk behavior in adolescent users of anabolic-androgenic steroids, by gender and athlete status. Sociol Sport J. 2002;19:385–402.
46. Goldberg L, Elliot DL, Mackinnon DP, et al. Drug testing athletes to prevent substance abuse: background and pilot study results of the SATURN (student athlete testing using random notification) study. J Adolesc Health. 2003;32(1):16–25.
47. Laure P, Lecerf T, Friser A, et al. Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med. 2004;25(2):133–8.
48. Lucidi F, Grano C, Leone L, et al. Determinants of the intention to use doping substances: an empirical contribution in a sample of Italian adolescents. Int J Sport Psychol. 2004;35(2):133–48.
49. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 2005.
50. Donahue EG, Miquelon P, Valois P, et al. A motivational model of performance-enhancing substance use in elite athletes. J Sport Exerc Psychol. 2006;28:511–20.
51. Kanayama G, Barry S, Hudson JI, et al. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006;163:697–703.
52. Papadopoulos FC, Skalkidis I, Parkkari J, et al. Doping use among tertiary education students in six developed countries. Eur J Epidemiol. 2006;21(4):307–13.
53. Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81(1):11–9.
54. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 2007.
55. Dodge T, Jaccard JJ. Negative beliefs as a moderator of the intention-behavior relationship: decisions to use performance-enhancing substances. J Appl Soc Psychol. 2007;37(1):43–59.
56. Elliot DL, Cheong J, Moe EL, et al. Cross-sectional study of female students reporting anabolic steroid use. Arch Pediatr Adolesc Med. 2007;161:572–7.
57. Laure P, Binsinger C. Doping prevalence among preadolescent athletes: a 4-year follow-up. Br J Sports Med. 2007;41(10):660–3.
58. Petróczi A. Attitudes and doping: a structural equation analysis of the relationship between athletes’ attitudes, sport orientation and doping behaviour. Subst Abuse Treat Prev Policy. 2007;2:34.
59. Wanjek B, Rosendahl J, Strauss B, et al. Doping, drugs and drug abuse among adolescents in the state of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med. 2007;28(4):346–53.
60. Al-Falasi O, Al-Dahmani K, Al-Eisaei K, et al. Knowledge, attitude and practice of anabolic steroids use among gym users in Al-Ain district, United Arab Emirates. Open Sports Med J. 2008;2:75–81.
61. Dodge T, Jaccard JJ. Is abstinence an alternative? Predicting adolescent athletes’ intentions to use performance enhancing substances. J Health Psychol. 2008;13(5):703–11.
62. Moran A, Guerin S, Kirby K, et al. The development and validation of a doping attitudes and behaviour scale. Report to World Anti-Doping Agency and The Irish Sports Council; 2008.
63. Petróczi A, Mazanov J, Nepusz T, et al. Comfort in big numbers: does over-estimation of doping prevalence in others indicate self-involvement? J Occup Med Toxicol. 2008;3:19.
64. Rees CR, Zarco EPT, Lewis DK. The steroids/sports supplements connection: pragmatism and sensation-seeking in the attitudes and behavior of JHS and HS students on Long Island. J Drug Educ. 2008;38(4):329–49.
65. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 2009.
66. Lugo R. Sports and health: The influence of motivational orientation on body image and doping behaviors [Master’s thesis]: Universitet I Oslo; 2009.
67. Ranby KW, Aiken LS, Mackinnon DP, et al. A mediation analysis of the ATHENA intervention for female athletes: prevention of athletic-enhancing substance use and unhealthy weight loss behaviors. J Pediatr Psychol. 2009;34(10):1069–83.
68. Rodek J, Sekulic D, Pasalic E. Can we consider religiousness as a protective factor against doping behavior in sport? J Relig Health. 2009;48(4):445–53.
69. Ip EJ, Barnett MJ, Tenerowicz MJ, et al. Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med. 2010;20(6):475–81.
70. Thorlindsson T, Halldorsson V. Sport, and use of anabolic androgenic steroids among Icelandic high school students: a critical test of three perspectives. Subst Abuse Treat Prev Policy. 2010;5:32.
71. Zelli A, Lucidi F, Mallia L. The relationships among adolescents’ drive for muscularity, drive for thinness, doping attitudes, and doping intentions. J Clin Sport Psych. 2010;4:39–52.
72. Centers for Disease Control and Prevention. National Youth Risk Behavior Survey (National High School); 2011.
73. Gucciardi DF, Jalleh G, Donovan RJ. An examination of the sport drug control model with elite Australian athletes. J Sci Med Sport. 2011;14(6):469–76.
74. Neeraj K, Maman P, Sandhu JS. Why players engage in drug abuse substances? A survey study. Doping J. 2011;8:1.
75. Petróczi A, Uvacsek M, Nepusz T, et al. Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust? PLoS One. 2011;6:e18804.
76. Allahverdipour H, Jalilian F, Shaghaghi A. Vulnerability and the intention to anabolic steroids use among Iranian gym users: an application of the theory of planned behavior. Subst Use Misuse. 2012;47(3):309–17.
77. Pope HG Jr, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012;71(3):254–61.
78. Barkoukis V, Lazuras L, Tsorbatzoudis H. Beliefs about the causes of success in sports and susceptibility for doping use in adolescent athletes. J Sports Sci. 2013;32(3):212–9.
79. Chan DKC, Hagger MS, Hardcastle SJ, et al. Behavioural, normative, and control beliefs of doping avoidance: a perspective from the theory of planned behaviour [unpublished]; 2013.
80. Tsorbatzoudis H, Barkoukis V, Lazuras L. Relation between doping behaviours and psychological variables [unpublished]; 2013.
81. Whitaker L. Applying the prototype willingness model to doping in sport [Doctoral thesis]: Leeds Metropolitan University; 2013.
82. Hunter JE, Schmidt FL. Methods of meta-analysis: correcting error and bias in research findings. 2nd ed. Thousand Oaks: Sage Publications, Inc.; 2004.
83. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions: The Cochrane Collaboration; 2011.
84. Shadish WR, Haddock CK. Combining estimates of effect size. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. p. 261–81.
85. Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat Simul Comput. 2010;39(4):860–4.
86. Cohen J. Statistical power analysis for the behavioral sciences. revised ed. New York: Academic Press; 1977.
87. Rosenthal R. The “file drawer problem” and tolerance for null results. Psychol Bull. 1979;86(3):638–41.
88. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557.
89. Hwang MI, Schmidt FL. Assessing moderating effect in meta-analysis: a re-analysis of top management support studies and suggestions for researchers. Eur J Inf Syst. 2011;20(6):693–702.
90. Landis RS. Successfully combining meta-analysis and structural equation modeling: recommendations and strategies. J Bus Psychol. 2013;28(3):251–61.
91. Viswesvaran C, Ones DS. Theory testing: combining psychometric meta-analysis and structural equations modeling. Pers Psychol. 1995;48(4):865–85.
92. Muthén B, Muthén L. Mplus user guide. Los Angeles: Muthén and Muthén; 2008.
93. Barkoukis V, Lazuras L, Tsorbatzoudis H, et al. Motivational and social cognitive predictors of doping intentions in elite sports: an integrated approach. Scand J Med Sci Sports. 2013;23(5):e330–40.
94. Hu L-T, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6(1):1–55.
95. Cheung GW, Rensvold RB. Evaluating goodness-of-fit indexes for testing measurement invariance. Struct Equ Modeling. 2002;9(2):233–55.
96. Petróczi A, Aidman E. Psychological drivers in doping: the life-cycle model of performance enhancement. Subst Abuse Treat Prev Policy. 2008;3:7.
97. Goldberg L, Elliot DL, Clarke GN, et al. The adolescents training and learning to avoid steroids (ATLAS) prevention program: background and results of a model intervention. Arch Pediatr Adolesc Med. 1996;150(7):713–21.
98. Goldberg L, Elliot DL. Preventing substance use among high school athletes: the ATLAS and ATHENA programs. J Appl Sch Psychol. 2005;21(2):63–87.
99. Elliot DL, Goldberg L, Moe EL, et al. Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program. Arch Pediatr Adolesc Med. 2004;158(11):1043–9.
100. Burns RD, Schiller MR, Merrick MA, et al. Intercollegiate student athlete use of nutritional supplements and the role of athletic trainers and dietitians in nutrition counseling. J Am Diet Assoc. 2004;104(2):246–9.
101. Maughan RJ, Depiesse F, Geyer H. The use of dietary supplements by athletes. J Sports Sci. 2007;25(S1):S103–13.
102. Hoffman JR, Faigenbaum AD, Ratamess NA, et al. Nutritional supplementation and anabolic steroid use in adolescents. Med Sci Sports Exerc. 2008;40(1):15–24.
103. Tscholl P, Alonso JM, Dollé G, et al. The use of drugs and nutritional supplements in top-level track and field athletes. Am J Sports Med. 2010;38(1):133–40.
104. Tsorbatzoudis H, Barkoukis V, Lazuras L. Determinants of doping intentions in sport–YOUTH. Montreal: World Anti-Doping Agency; 2013.
105. Ajzen I. The theory of planned behaviour: reactions and reflections. Psychol Health. 2011;26(9):1113–27.
106. Stewart B, Smith ACT. Drug use in sport: implications for public policy. J Sport Soc Issues. 2008;32(3):278–98.
107. Geyer H, Parr MK, Koehler K, et al. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008;43(7):892–902.
108. Donovan RJ, Egger G, Kapernick V, et al. A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Med. 2002;32(4):269–84.
109. Strelan P, Boeckmann RJ. A new model for understanding performance-enhancing drug use by elite athletes. J Appl Sport Psychol. 2003;15(2):176–83.
110. Rivis A, Sheeran P. Descriptive norms as an additional predictor in the theory of planned behaviour: a meta-analysis. Curr Psychol. 2003;22(3):218–33.
111. Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol. 2001;40(4):471–99.
112. McEachan RRC, Conner M, Taylor NJ, et al. Prospective prediction of health-related behaviours with the theory of planned behaviour: a meta-analysis. Health Psychol Rev. 2011;5(2):97–144.
113. Simons-Morton BG, Haynie D, Noelcke E. Social influences: the effects of socialization, selection, and social normative processes on health behavior. In: DiClemente RJ, Crosby RA, Kegler M, editors. Emerging theories in health promotion practice and research. San Francisco: Wiley; 2009. p. 65–95.
114. Backhouse SH, Patterson L, McKenna J. Achieving the Olympic ideal: preventing doping in sport. Perform Enhanc Health. 2012;1(2):83–5.
115. Gardner M, Steinberg L. Peer influence on risk taking, risk preference, and risky decision making in adolescence and adulthood: an experimental study. Dev Psychol. 2005;41(4):625–35.
116. Albert D, Chein J, Steinberg L. The teenage brain: peer influences on adolescent decision making. Curr Dir Psychol Sci. 2013;22(2):114–20.
117. Cialdini RB. Crafting normative messages to protect the environment. Curr Dir Psychol Sci. 2003;12(4):105–9.
118. Schultz PW, Nolan JM, Cialdini RB, et al. The constructive, destructive, and reconstructive power of social norms. Psychol Sci. 2007;18(5):429–34.